GE, Cardinal Say Imaging Drug Antitrust Claims Lack Specifics

Law360, New York (November 14, 2012, 1:54 PM EST) -- GE Healthcare Inc. and Cardinal Health Inc. urged a California federal court Tuesday to toss a radiopharmacy owner's putative antitrust class action, saying the suit failed to specifically allege a plausible anti-competitive conspiracy, a problem that doomed an earlier version of the complaint.

In separate motions to dismiss, GE and Cardinal both said that a second amended complaint filed by radiopharmacy owner PharmaRx Pharmaceutical Inc. — which alleges that a distribution deal between GE and Cardinal on cardiac imaging agents violated antitrust laws — suffered from...
To view the full article, register now.